Balancing the risks and benefits of extended adjuvant endocrine therapy. Article uri icon

Overview

publication date

  • February 1, 2019

Research

keywords

  • Antineoplastic Agents, Hormonal
  • Breast Neoplasms

Identity

Scopus Document Identifier

  • 85062586062

PubMed ID

  • 30845113

Additional Document Info

volume

  • 17

issue

  • 2